AwardedPOLGoods
Dostawa produktów leczniczych zawierających substancje Acalabrutinibum, Ravulizumabum oraz Trastuzumabum derutecan finansowanych w ramach Programów Lekowych
- Published
- Published 2 July 2026
Overview
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie procured delivery of pharmaceutical products containing Acalabrutinibum, Ravulizumabum, and Trastuzumabum derutecan financed under drug programs. The contract was awarded to Astrazeneca Kft. on 11 May 2026 for 238,000.03 PLN.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Selective
- Published
- 2 July 2026
Pharmaceutical products
Award outcome
- Awarded value
- PLN 238,000
- Award date
- 11 May 2026
- Contract period
- — → 6 May 2027
- Astrazeneca Kft.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
2 July 2026
Contracting authority
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie
Procuring entityLublin, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.